ijms-logo

Journal Browser

Journal Browser

Advances in Sepsis: Molecular and Biochemical Perspectives

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: 20 November 2026 | Viewed by 1005

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biological Applications & Technology, Faculty of Health Sciences, University of Ioannina, 45110 Ioannina, Greece
Interests: neutrophils/NETs; immunity; inflammation; thrombosis; fibrosis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Sepsis stands out among critical conditions in contemporary clinical practice as a multifaceted challenge marked by a dysregulated host response to infection that can lead to organ dysfunction and mortality. The mechanisms underlying sepsis involve complex interactions between pathogens, immune cells, inflammatory mediators, and alterations in the microbiome, making the understanding of its pathophysiology imperative for effective management. As the interplay of these biological components varies widely from patient to patient, recognizing sepsis’s heterogeneity is crucial for tailoring therapeutic strategies. Traditional molecular and biochemical diagnostic approaches could delay appropriate treatment initiation.

There is still an urgent need to diagnose, stratify, and monitor sepsis early in order to develop novel and improved molecular diagnostic and biochemical techniques for gene expression, epigenetic modifications, proteomic and metabolic signatures, and machine learning algorithms, which may uncover features that offer novel insights into understanding immune dysfunctions.

These approaches will provide hope of discovering new biomarkers for the development of future therapies and, moreover, underline personalized therapeutic approaches in managing sepsis, because the traditional one-size-fits-all approach to sepsis management is increasingly deemed insufficient considering each individual patient’s inflammatory and immune status (different phenotype), such as their sepsis inflammatory endotype classification.

This Special Issue is Guest Edited by Dr. Akrivi Chrysanthopoulou, assisted by Dr. Asimina Safarika and Dr. Spyros Foutadakis (Hellenic Institute for the Study of Sepsis). We welcome original research manuscripts and review articles on the development of better diagnostic tools offering novel insights into the development of new therapeutic strategies in sepsis to improve the survival and quality of life of patients affected by this life-threatening condition. 

Dr. Akrivi Chrysanthopoulou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • sepsis
  • outcome
  • molecular diagnosis
  • machine learning
  • biochemical biomarkers
  • targeted immunotherapy
  • personalized medicine
  • sepsis inflammatory endotypes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 247 KB  
Article
XPO5 Polymorphism in Colon Cancer Patients: A Cross-Sectional Study
by Tugba Agbektas, Husnu Cagrı Genc, Cemile Zontul and Ayca Tas
Int. J. Mol. Sci. 2026, 27(1), 345; https://doi.org/10.3390/ijms27010345 - 29 Dec 2025
Viewed by 511
Abstract
(1) This cross-sectional study aims to elucidate the association between the XPO5 gene polymorphism (rs11544382) and colon cancer (CC). (2) Genotyping of XPO5 (rs11544382) was performed in 120 individuals (60 CC patients and 60 controls) using real-time PCR (qPCR). Logistic regression and Chi-square [...] Read more.
(1) This cross-sectional study aims to elucidate the association between the XPO5 gene polymorphism (rs11544382) and colon cancer (CC). (2) Genotyping of XPO5 (rs11544382) was performed in 120 individuals (60 CC patients and 60 controls) using real-time PCR (qPCR). Logistic regression and Chi-square (χ2) tests were used for statistical analysis. (3) Evaluation of the XPO5 gene polymorphism in CC and control groups revealed no statistically significant association between the mutant (GG) genotype and either the wild-type (AA) or heterozygous (AG) genotypes (χ2 = 2.07, p = 0.151). The AG genotype was predominant in both patients (86.7%) and controls (91.7%). Smoking and alcohol consumption showed significant associations with CC (p < 0.05). Although the rs11544382 polymorphism was not associated with CC risk, this is a cross-sectional study. In light of these findings, larger and more comprehensive studies with increased sample size are required to clarify the relationship between the XPO5 gene polymorphism (rs11544382) and CC. Full article
(This article belongs to the Special Issue Advances in Sepsis: Molecular and Biochemical Perspectives)
Back to TopTop